怀孕妇女患有严重的症状性大动脉狭窄症:我们应该如何治疗?
Oren Yagel1, Roie Alter2, Batel Nissan1
1Department of Cardiology, Hadassah Medical Center, The Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
JACC. Case reports
|February 16, 2024
概括
一名患有严重大动脉狭窄和末期脏病的孕妇接受了紧急的跨导管大动脉置换. 这种挽救生命的手术在怀孕期间治疗了她的急性心力衰竭.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 孕产妇和胎儿医学 孕产妇和胎儿医学
背景情况:
- 一名31岁的孕妇患有末期脏病和双主动脉,呈现急性心力衰竭.
- 她在怀孕的第二个三个月被诊断出患有严重的大动脉狭窄.
相关概念视频
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
448
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
448
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
431
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
431